Experts Advocate Easing NDA Clinical Trial Requirements For Nicotine Replacement Therapies
This article was originally published in The Pink Sheet Daily
Executive Summary
Experts recommend relaxing the clinical studies requirement for NDAs submitted for NRTs, saying many proposed new products would be bioequivalent to or have the same ingredients as products already on the market.